quinoxalines has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diab-Assef, M; El-Sabban, M; Gali-Muhtasib, H; Haddadin, M; Harakeh, S | 1 |
1 other study(ies) available for quinoxalines and Leukemia, T-Cell
Article | Year |
---|---|
Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide in adult T-cell leukemia cells.
Topics: Adult; Apoptosis; CD4-Positive T-Lymphocytes; Cell Death; Cell Division; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Human T-lymphotropic virus 1; Humans; Jurkat Cells; Leukemia, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinoxalines | 2004 |